Search

everythinglearnresearchcommunity

for

Search:↓

Sun-exposed skin shows different cell activity and gene expression, suggesting targets to prevent skin aging and cancer.

Certain drugs can cause hair loss, but stopping the drug usually leads to hair regrowth.

Piperonylic acid speeds up wound healing by reducing inflammation and boosting collagen.

Switching from adalimumab to ixekizumab improved a patient's psoriasis and reversed hair whitening.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

AGEs may cause hair loss by increasing inflammation in hair follicles.

Early diagnosis and treatment are crucial to prevent permanent hair loss from TNFα inhibitors in scalp psoriasis.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

Aging changes hair stem cells and their environment, leading to gray hair and hair thinning, but understanding these changes could help develop treatments for hair regeneration.

Some drugs used to treat immune conditions may cause different types of hair loss.

Biologics and small molecules can effectively treat inflammatory nail disorders, but personalized treatment plans are important.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

Depression and skin autoimmune diseases are linked, needing combined care for better treatment.

COVID-19 vaccines have been linked to an increase in hair loss conditions.

A woman's rare scalp condition worsened after using a specific arthritis medication, suggesting such medications can sometimes trigger or aggravate psoriasis.

New cytokine-targeted therapies show promise for treating alopecia areata.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

Hidradenitis Suppurativa is a chronic skin condition best treated early with surgery for better outcomes and less recurrence.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

Anti-TNF therapy can cause a rare hair loss condition similar to alopecia areata.

Intralesional methotrexate effectively treats patchy alopecia areata by reducing inflammation.

Punica granatum leaf extract may help treat skin fibrosis by reducing inflammation and oxidative stress.

TNFα inhibitors are effective and well-tolerated for treating severe scalp cellulitis.

Higher levels of DHEA and TNF-α are linked to PCOS symptoms.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

Accurate diagnosis and new therapies are crucial for effectively treating certain types of hair loss.

Leflunomide may lower alopecia areata risk, while other immunomodulators might increase it.

Psoriasis patients are more likely to develop alopecia areata due to complex autoimmune interactions.

The new hydrogel speeds up wound healing by reducing inflammation and promoting tissue growth.

TNF-α blockers and IL inhibitors improve symptoms in most patients with severe scalp condition, but more research is needed.